Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
117 hedge funds and large institutions have $475M invested in Surmodics in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 40 reducing their positions, and 5 closing their positions.
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
20% more capital invested
Capital invested by funds: $395M → $475M (+$80.4M)
14% more funds holding
Funds holding: 103 → 117 (+14)
4.86% more ownership
Funds ownership: 86.97% → 91.83% (+4.9%)
3% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 40
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $131K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$36.7M |
| 2 |
RA
Royce & Associates
New York
|
+$4.32M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.67M |
| 4 |
BlackRock
New York
|
+$1.88M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$15M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.96M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.12M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.6M |
| 5 |
Squarepoint
New York
|
-$1.32M |
SRDX Hedge Fund Activity: Q4 2023 in Review
117 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2023, worth a combined $475M — up 20% from $395M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SRDX positions and 5 closed out — a net gain of 14 holders — while 41 added to existing stakes and 40 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $36.7M. The largest seller was Soleus Capital Management, cutting an estimated $15M.
- 117 institutional investors held Surmodics (SRDX) as of Q4 2023, up from 103 in Q3 2023.
- Funds reported $475M of Surmodics stock for Q4 2023, up 20% quarter-over-quarter.
- 19 funds opened new Surmodics positions in Q4 2023 and 5 closed out, a net change of +14 holders.
- The largest Surmodics buyer in Q4 2023 was Morgan Stanley, an estimated $36.7M added.
- The largest Surmodics seller in Q4 2023 was Soleus Capital Management, an estimated $15M sold.
Based on aggregated 13F filings for Q4 2023.